On October 1, 2006, Columbia University was one of the first 12 institutions in the country to receive a Clinical and Translational Science Award (CTSA) from the National Institutes of Health. Combined with increased support from our long-time benefactors, Herbert and Florence Irving, this award enabled the former Irving Center for Clinical Research (GCRC) to evolve into the Irving Institute for Clinical and Translational Research thereby becoming the academic and intellectual home for the next generation of clinical and translational research investigators at Columbia University. Continuing the tradition of clinical research first started at Columbia in 1928, the focus of the Irving Institute is to transform the way clinical and translational research is conducted, enabling medical investigators to develop new treatments faster, and to deliver those treatments to patients more efficiently and more effectively. The Irving Institute has been continually funded through the CTSA program since 2006 and successfully renewed its third 5-year cycle funding in July 2016.

The Irving Institute provides outstanding support and resources to Columbia University researchers including¬† biomedical informatics services, biostatistics and research design, data management, community engagement, regulatory and bioethics support, clinical research facilities, pilot funding programs, access to the CTSA Trial Innovation Network, and core laboratory resources. As part of the CTSA program, the Irving Institute houses an integrated educational program that includes short-term training, a patient-oriented master’s degree, a novel KL2 mentored research program in multi- and interdisciplinary research, and a TL1 training program with three distinct tracks for doctoral students, postdoctoral fellows, and a 12-week summer program. In addition, the Irving Institute hosts several ongoing seminar series, research events and special symposia. In its current CTSA grant funding cycle and in synergy with a major Columbia University initiative in precision medicine, the Irving Institute initiated multiple new programs in precision medicine including education, training, and fellowships, an institutional biorepository, biomedical informatics, translational therapeutics, and community precision health. ¬†

Faculty funded by the Irving Institute provide leadership and serve as mentors for both junior faculty and trainees.

Our goals include:
  • Changing the culture of research so that individual investigators can seek out and easily collaborate with other investigators in both similar and different areas of biomedical research.
  • Effecting institutional changes to ensure that multi- and interdisciplinary clinical and translational research and mentorship is recognized, supported and promoted appropriately.
  • Training and educating MDs and PhDs who will become agents of change as they translate basic science findings to the treatment of people.
  • Improving the health and well-being of our patients and neighbors in Northern Manhattan.

In pursuit of these goals, we are joined by a dedicated group of Associate Directors, Executive Leaders and staff members.

DR. Reilly

Muredach P. Reilly, MB, MS
Herbert and Florence Irving Professor of Medicine
Associate Dean for Clinical and Translational Research
Director and Principal Investigator,
Irving Institute for Clinical and Translational Research

Source: Jorg Meyer 2016